Annexon shares are trading higher after a Form4 filing showed BCIP Life Sciences Associates bought 300,000 shares at an average price of $2.13.
Portfolio Pulse from Benzinga Newsdesk
Annexon's stock is trading higher after BCIP Life Sciences Associates purchased 300,000 shares at an average price of $2.13, according to a Form4 filing.
May 31, 2023 | 7:49 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Annexon's stock price is likely to increase in the short term due to BCIP Life Sciences Associates' purchase of 300,000 shares at an average price of $2.13.
The purchase of 300,000 shares by BCIP Life Sciences Associates, a significant investor, at an average price of $2.13 indicates confidence in Annexon's potential. This insider trading activity is likely to have a positive impact on ANNX's stock price in the short term, as it signals to other investors that the company is worth investing in.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100